Because DPC4 protein loss is correlated with SMAD4/DPC4 mutation, immunohistochemical staining for DPC4 protein is used as a diagnostic criteria of pancreatic cancer with lower cost than sequencing of SMAD4/DPC4 [50]. Here, SMAD4 is linked to pancreatic neoplasm.